New DCO Trends report says rapid advances in AI and frontier technologies will push the digital economy to 28 trillion ...

The American University in Cairo (AUC) and Minapharm Pharmaceuticals announced a new strategic partnership to strengthen ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

Results from SCOPE to date have enabled Scancell to select Immunobody iSCIB1+, administered needle-free intramuscularly, for further development in patients with selected human leukocyte antigen (HLA) ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

We are pleased to welcome Dr. Lee and Dr. Murphy to our Board at an important time for Century as we execute with discipline and focus to bring our most differentiated iPSC-derived cell therapy ...

Companies who run their early-stage clinical development outside the U.S. would “experience higher fees” according to an FDA ...

An update from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings has announced positive updated data from its SCOPE Phase 2 ...

China's systematic intellectual property theft campaign poses unprecedented threats to American national security and ...

Get a Free Sample PDF copy of the report @- The trajectory of the Epigenetics Market is shaped by a myriad of factors. Firstly, the growing application of epigenetics in non-oncology diseases and the ...

Aether Biomachines use an AI process to identify novel materials, then build them with biotechnology. They are the first ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...